BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21107098)

  • 1. Phenotypic alterations in myoepithelial cells of the breast in normal and pathologic conditions.
    Pusztaszeri M
    Am J Surg Pathol; 2010 Dec; 34(12):1886; author reply 1886-7. PubMed ID: 21107098
    [No Abstract]   [Full Text] [Related]  

  • 2. Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast.
    Tramm T; Kim JY; Tavassoli FA
    Am J Surg Pathol; 2011 Feb; 35(2):202-11. PubMed ID: 21263240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells: biologic and diagnostic implications.
    Hilson JB; Schnitt SJ; Collins LC
    Am J Surg Pathol; 2009 Feb; 33(2):227-32. PubMed ID: 18936688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.
    Rabban JT; Chen YY
    Hum Pathol; 2008 Feb; 39(2):175-83. PubMed ID: 18206495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic alterations in myoepithelial cells associated with benign sclerosing lesions of the breast.
    Hilson JB; Schnitt SJ; Collins LC
    Am J Surg Pathol; 2010 Jun; 34(6):896-900. PubMed ID: 20463570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial displacement into the lymphovascular space can be seen in breast core needle biopsy specimens.
    Koo JS; Jung WH; Kim H
    Am J Clin Pathol; 2010 May; 133(5):781-7. PubMed ID: 20395526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D2-40: an additional marker for myoepithelial cells of breast and the precaution in interpreting tumor lymphovascular invasion.
    Ren S; Abuel-Haija M; Khurana JS; Zhang X
    Int J Clin Exp Pathol; 2011 Jan; 4(2):175-82. PubMed ID: 21326813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal cell-specific and hyperproliferation-related keratins in human breast cancer.
    Wetzels RH; Kuijpers HJ; Lane EB; Leigh IM; Troyanovsky SM; Holland R; van Haelst UJ; Ramaekers FC
    Am J Pathol; 1991 Mar; 138(3):751-63. PubMed ID: 1705754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual usages of single Wilms' tumor 1 immunohistochemistry in evaluation of breast tumors: a preliminary study of 30 cases.
    Li JH; Man YG
    Cancer Biomark; 2009; 5(3):109-16. PubMed ID: 19407365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel myoepithelial/progenitor cell marker in the breast?
    Kolar Z; Ehrmann J; Turashvili G; Bouchal J; Mokry J
    Virchows Arch; 2007 May; 450(5):607-9. PubMed ID: 17429688
    [No Abstract]   [Full Text] [Related]  

  • 11. Massive myoepithelial proliferation (myoepitheliosis) with lumpy deposits of basement membrane material closely associated with apocrine adenosis and ductal carcinoma in situ of the breast.
    Kawasaki T; Oyama T; Nakagomi H; Furuya K; Kondo T; Nakazawa T; Mochizuki K; Yamane T; Miyazawa T; Ishii Y; Fukushima K; Moriya T; Tsunoda H; Katoh R
    Pathol Int; 2011 Oct; 61(10):615-7. PubMed ID: 21951673
    [No Abstract]   [Full Text] [Related]  

  • 12. Loss of myoepithelium is variable in solid papillary carcinoma of the breast.
    Nicolas MM; Wu Y; Middleton LP; Gilcrease MZ
    Histopathology; 2007 Nov; 51(5):657-65. PubMed ID: 17927587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
    Krop IE; Sgroi D; Porter DA; Lunetta KL; LeVangie R; Seth P; Kaelin CM; Rhei E; Bosenberg M; Schnitt S; Marks JR; Pagon Z; Belina D; Razumovic J; Polyak K
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9796-801. PubMed ID: 11481438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DCIS and LCIS with multinucleated giant cells-a report of 4 cases.
    Coyne JD
    Histopathology; 2007 Apr; 50(5):669-71. PubMed ID: 17394507
    [No Abstract]   [Full Text] [Related]  

  • 15. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of disease: breast tumor pathogenesis and the role of the myoepithelial cell.
    Barsky SH; Karlin NJ
    Nat Clin Pract Oncol; 2006 Mar; 3(3):138-51. PubMed ID: 16520804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcomatoid breast tumors have sarcomatoid behavior.
    Gilcrease MZ
    Am J Surg Pathol; 2007 Feb; 31(2):326-7; author reply 327. PubMed ID: 17255781
    [No Abstract]   [Full Text] [Related]  

  • 18. Best practices in diagnostic immunohistochemistry: myoepithelial markers in breast pathology.
    Dewar R; Fadare O; Gilmore H; Gown AM
    Arch Pathol Lab Med; 2011 Apr; 135(4):422-9. PubMed ID: 21466356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two score systems in Bcl-2 and Bax protein expression in invasive ductal carcinoma of breast and relation with oestrogen and progestrone receptors.
    Ayatollahi H; Ghaffarzadegan K; Sharifi N; Farahmand MJ; Jarafian AH
    Breast J; 2009; 15(3):310-2. PubMed ID: 19645793
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibodies targeting p63 react specifically in the cytoplasm of breast epithelial cells exhibiting secretory differentiation.
    Bratthauer GL; Saenger JS; Strauss BL
    Histopathology; 2005 Dec; 47(6):611-6. PubMed ID: 16324199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.